Randomized study of dual versus single ritonavir-enhanced protease inhibitors for protease inhibitor-experienced patients with HIV.
about
Outcomes of patients on dual-boosted PI regimens: experience of the Swiss HIV cohort studyBarriers to antiretroviral therapy adherence and plasma HIV RNA suppression among AIDS clinical trials group study participantsHIV-Antiretroviral Therapy Induced Liver, Gastrointestinal, and Pancreatic Injury.Brief Report: Significant Decreases in Both Total and Unbound Lopinavir and Amprenavir Exposures During Coadministration: ACTG Protocol A5143/A5147s Results.Peripheral neuropathy in ART-experienced patients: prevalence and risk factors
P2860
Randomized study of dual versus single ritonavir-enhanced protease inhibitors for protease inhibitor-experienced patients with HIV.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Randomized study of dual versu ...... experienced patients with HIV.
@en
Randomized study of dual versu ...... experienced patients with HIV.
@nl
type
label
Randomized study of dual versu ...... experienced patients with HIV.
@en
Randomized study of dual versu ...... experienced patients with HIV.
@nl
prefLabel
Randomized study of dual versu ...... experienced patients with HIV.
@en
Randomized study of dual versu ...... experienced patients with HIV.
@nl
P2093
P2860
P356
P1433
P1476
Randomized study of dual versu ...... experienced patients with HIV.
@en
P2093
AIDS Clinical Trials Group Protocol A5143 Team
Alex Rinehart
Angela Kashuba
Ann C Collier
Camlin Tierney
Emanuel N Vergis
Gary E Pakes
Gerald F Downey
James F Rooney
John W Mellors
P2860
P304
P356
10.1310/HCT0902-91
P577
2008-03-01T00:00:00Z